Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-03-29
1991-10-01
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514971, 5482678, 5482686, A01N 4364, C07D24914
Patent
active
050534211
ABSTRACT:
In the spraying of an aqueous liquor comprising at least one of 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-yl-methyl)-pentan-3-ol and 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)-butan-2-ol, the improvement which comprises including in the liquor di-styryl-phenyl-tri-glycol ether, whereby crystallization of II and III is reduced.
REFERENCES:
patent: 3952002 (1976-04-01), Kramer et al.
patent: 4348385 (1982-09-01), Synek
patent: 4723984 (1988-02-01), Holmwood et al.
patent: 4943299 (1990-07-01), Schulze et al.
Bartkowiak Frank
Boehmke Gunther
Engelhardt Ulrich
Horstmann Heinz-Otto
Reizlein Karl
Bayer Aktiengesellschaft
Robinson Allen J.
LandOfFree
Di-styrl-phenyl-triglycol ether as crystallization inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Di-styrl-phenyl-triglycol ether as crystallization inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di-styrl-phenyl-triglycol ether as crystallization inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755245